Cabot Corporation 10-Q Summary: Quarter Ended June 30, 2003
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2003, and the nine-month period ended June 30, 2003, for Cabot Corporation, a Delaware corporation. The company operates in three primary segments: Chemical Businesses (carbon black, fumed metal oxides, inkjet, aerogel), Supermetals (tantalum products), and Specialty Fluids. The financial statements are unaudited and reflect normal recurring adjustments.
Key Financial Metrics
| Metric (in millions) | Q3 2003 | Q3 2002 | 9M 2003 | 9M 2002 |
|---|---|---|---|---|
| Net Sales | $468 | $390 | $1,344 | $1,117 |
| Gross Profit | $101 | $98 | $346 | $318 |
| Operating Income (Loss) | $(8) | $24 | $104 | $120 |
| Net Income (Loss) | $(5) | $19 | $52 | $84 |
| Diluted EPS | $(0.09) | $0.28 | $0.74 | $1.17 |
| Cash from Operations (9M) | $156 | $115 | ||
| Total Assets | $2,200 (as of June 30, 2003) | |||
| Total Debt | $548 (Long-term $530 + Current $18) | |||
| Cash & Equivalents | $179 (as of June 30, 2003) |
Material Changes vs. Prior Period
- Quarterly Performance: The company reported a net loss of $5 million for Q3 2003, a reversal from the $19 million net income in Q3 2002. This decline was driven by $46 million in specific charges and discontinued operations items, including a $20 million reserve for respirator claims, $17 million in restructuring costs, and $14 million in expensed in-process R&D from an acquisition.
- Revenue Growth: Net sales increased 20% year-over-year for the nine-month period ($1,344 million vs. $1,117 million), driven by favorable foreign exchange rates, higher pricing in Chemical Businesses, and increased volumes in Supermetals.
- Segment Results:
- Chemical Businesses: Sales up 15%; operating profit up 11% to $30 million, aided by favorable foreign exchange ($12 million) but offset by lower volumes and reduced margins due to rising raw material costs.
- Supermetals: Sales up 42% to $92 million; operating profit increased $4 million to $14 million, driven by higher volumes despite lower average selling prices due to contract renegotiations.
- Specialty Fluids: Sales increased to $7 million; operating loss remained at $1 million due to weak drilling activity.
- Acquisition: On May 30, 2003, Cabot acquired Superior MicroPowders (SMP) for $16 million. $14 million of the purchase price was allocated to in-process R&D and immediately expensed.
Guidance, Outlook, Risks, and Unusual Items
- Restructuring Plan: In May 2003, Cabot initiated a restructuring plan expected to result in a pre-tax charge of approximately $60 million over the next 18 to 24 months. This includes the closure of a carbon black facility in Zierbena, Spain, and consolidation of European administrative services. Approximately $50 million is expected to be recorded in fiscal 2003.
- Respirator Liability: Cabot recorded a $20 million reserve for its share of liability regarding respirator claims (asbestosis/silicosis) stemming from a 1990 acquisition. The number of claimants rose from 50,000 to 84,000 between late 2002 and June 2003. The company notes significant uncertainty regarding future costs.
- Outlook: Management is cautious regarding the business outlook. Downward pricing pressure and rising raw material costs threaten margins in Chemical Businesses. Supermetals earnings are expected to decline significantly in fiscal 2004 as a customer's obligation to purchase intermediate products expires. Specialty Fluids results are expected to improve in fiscal 2004 due to signs of recovery in the oil drilling market.
- Dividends: On July 11, 2003, the Board increased the quarterly dividend to $0.15 per share.
- Legal Proceedings: Cabot is a defendant in antitrust lawsuits regarding carbon black pricing, alleging price-fixing from 1999 to the present. The company believes it has strong defenses.
Key Facts for Investor Verification
- Respirator Liability Reserve: Verify the assumptions used by the external expert (HR&A) for the $20 million reserve, given the rapid increase in claimants and the complexity of the indemnity agreements with the "Payor Group."
- Restructuring Costs: Monitor the execution of the $60 million restructuring plan, specifically the timeline for the Zierbena, Spain facility closure and the associated cash outlays.
- Supermetals Contract Expiry: Assess the impact of the expiring customer obligation for intermediate products on Supermetals earnings in fiscal 2004.
- Antitrust Litigation: Track the status of the multidistrict litigation consolidation and potential exposure from carbon black price-fixing allegations.
- Revenue Recognition: Review the $9 million deferred revenue balance related to multi-year supply contracts with declining prices and the recognition schedule extending through 2006.